Sweden
Nordic Biomarker, founded in 2007, stands out as a significant player in the biotechnology sector with a sharp focus on coagulation and clinical chemistry instruments. Headquartered in Sweden, the company establishes itself as a trusted original manufacturer of advanced reagents for coagulation analyzers.
Providing value with CE-marked kits and bespoke OEM solutions, Nordic Biomarker emphasizes swift customer service and technical support, driven by its highly qualified staff. Their distinct selling proposition includes short lead times, production tailored to orders for optimal shelf life, and continuous research that feeds an expanding product portfolio.
Positioned as an ideal collaboration companion, the company offers a comprehensive hemostasis reagent package for enterprises aiming for seamless integration. While details of any recent investments or investors are undisclosed, Nordic Biomarker presents a promising profile for potential venture capital interest, given its robust operational framework and innovative product offerings.
Oculer Limited